foxo4-dri senolytic peptide mechanism Class II senolytics inhibit survival pathways elicited by senescent FOXO4-DRI For Sale (10mg) -
FOXO4 DRI For Sale (10mg) Core Peptides FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOX04 DRI (10mg) Nordsci The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity.
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


